Pfizer Valuation Multiples

Pfizer Overview

About Pfizer

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Founded

1942

HQ

Employees

75.0K

Website

pfizer.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $62B

EBITDA: $24B

EV

$202B

Valuation Multiples

Multiples.vc

Start free trial

Pfizer Financials

Pfizer reported last 12-month revenue of $62B and EBITDA of $24B.

In the same LTM period, Pfizer generated $47B in gross profit, $24B in EBITDA, and $18B in net income.

Pfizer P&L

In the most recent fiscal year, Pfizer reported revenue of $63B and EBITDA of $24B.

Pfizer expects next 12-month revenue of XXX and NTM EBITDA of XXX

Pfizer Stock Performance

Pfizer has current market cap of $151B, and enterprise value of $202B.

Pfizer's stock price is $26.61.

Pfizer Valuation Multiples

Pfizer trades at 3.2x EV/Revenue multiple, and 8.3x EV/EBITDA.

Pfizer Financial Valuation Multiples

As of April 6, 2026, Pfizer has market cap of $151B and EV of $202B.

Equity research analysts estimate Pfizer's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Pfizer has a P/E ratio of 8.4x.

Pfizer Margins & Growth Rates

Pfizer's revenue in the last 12 month declined by (3%).

Pfizer's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.4M for the same period.

Pfizer's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pfizer's rule of X is 35% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Pfizer Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Pfizer M&A Activity

Pfizer acquired XXX companies to date.

Last acquisition by Pfizer was on XXXXXXXX, XXXXX. Pfizer acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Pfizer Investment Activity

Pfizer invested in XXX companies to date.

Pfizer made its latest investment on XXXXXXXX, XXXXX. Pfizer invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).